Charles River Laboratories International Inc (NYSE:CRL)
$ 235.675 2.855 (1.23%) Market Cap: 12.14 Bil Enterprise Value: 14.75 Bil PE Ratio: 27.66 PB Ratio: 3.33 GF Score: 95/100

Charles River Laboratories International Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2021 / 03:20PM GMT
Release Date Price: $354.78 (+2.56%)
Robert Patrick Jones
Goldman Sachs Group, Inc., Research Division - VP

Okay. Good morning, everyone. Welcome to the Charles River Laboratories session. I'm Bob Jones. I'm joined by my colleague, Jack Rogoff. Together, we cover the CROs here at Goldman.

Very excited to have Girshick -- I'm sorry, Birgit Girshick from Charles River Laboratories with us today. Welcome and thank you so much for doing this.

Birgit Girshick
Charles River Laboratories International, Inc. - Corporate EVP of Global Discovery & Safety Assessment, Biologics Testing Solutions & Avian Vaccine

Thank you very much, Bob. Thanks for having me.

Robert Patrick Jones
Goldman Sachs Group, Inc., Research Division - VP

Just for a background, Birgit actually has quite a number of responsibilities these days, Executive VP of Discovery and Safety Assessment, Biologics Solutions, CDMO and Avian Vaccine Services. So several hats, and I'm sure you've been very busy these days given all that's going on within Charles River.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot